# active_site_0041

[All questions and paired results](../README.md) · [Method](../METHOD.md) · [Source credits](../THIRD_PARTY_NOTICES.md)

**Task:** `active_site`  
**Author expected answer:** **D** — Position 58 (Proton donor)

| Reviewer | Expected-answer support | Reasoning / lookup | Validity |
|---|---|---|---|
| GPT-6 Luna | supported | lookup-dependent | valid_review |
| Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | valid_review |

**Paired comparison:** key agree; reasoning differ. Agreement is not proof of correctness. These are separate AI judgments, with no forced consensus or changed key.

## Complete original question

```text
[Protein Sequence]
MEKQVQMPEVELNSDHKMPLVGFGTCIPDPIPPLEELATIFLEVIKVGYRHFDTASCYGTEEALGKAVAQAIESGLVNGREEFFITSKLWVEDADQDLILPALKKTLGNLGLDYLDLYLIHMPLRLRQGAEMFKYTKEDFLPFDIKGTWKAMEECSKLGLCKSIGVSNYSCEKLSKLLENATILPAVNQVEMNVVWKQSKLLPFCKEKNIHVSAWSPLLSYGSIWSQNAVMENTVLVDIAASKSKTVAQVALRWIYEQGASFIMRTFNKERMYQNVQIFDWELTQEELDQIQQIPQRRSNLAEAFVHPEGPIKSVEELWDGDL

[Multiple Choices]
A. Position 2886 (For beta-ketoacyl synthase 2 activity)
B. Position 125 (Proton donor)
C. Position 157 (Proton acceptor)
D. Position 58 (Proton donor)
```

<details>
<summary>Original system instructions, verbatim</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Enzyme Active Site Prediction, which is to identify the key amino acid residues that form the active site of an enzyme. The active site is the specific region on the enzyme where a substrate binds and the chemical reaction is catalyzed. Based on the full protein sequence provided, you must select the option that correctly lists the amino acid residues (by their type and position) that constitute the enzyme's catalytic center.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## GPT-6 Luna

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The matched UniProt record annotates residue 58 as the proton donor, supporting choice D. The annotation is transferred by similarity rather than direct experimental evidence for this sequence.

Citations as saved: [C1](#evidence-c1), [C5](#evidence-c5), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence alone does not provide a reliable way to distinguish which listed residue is the proton donor; the out-of-range position in A is readily excluded, but that does not identify the catalytic residue.


**Missing item-specific fact**

> The protein-specific active-site annotation identifying residue 58 as the proton donor, or equivalent experimental or homology evidence.


**Reason**

> The exact residue and catalytic role are protein-specific facts not established by the supplied sequence and choices through general biological reasoning.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The available matched-sequence annotation supports D; no other listed option is supported as the proton donor.


### Important caveats

- The residue-58 annotation cites evidence transferred from UniProtKB:Q8CG76 (ECO:0000250), not direct experimental validation for this protein.
- The sequence match is established for the retrieved current and historical records, but the author's exact source snapshot is unknown.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence alone does not provide a reliable way to distinguish which listed residue is the proton donor; the out-of-range position in A is readily excluded, but that does not identify the catalytic residue.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein-specific active-site annotation identifying residue 58 as the proton donor, or equivalent experimental or homology evidence.",
    "reason": "The exact residue and catalytic role are protein-specific facts not established by the supplied sequence and choices through general biological reasoning."
  },
  "case_id": "active_site_0041",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C5",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The matched UniProt record annotates residue 58 as the proton donor, supporting choice D. The annotation is transferred by similarity rather than direct experimental evidence for this sequence."
  },
  "important_caveats": [
    "The residue-58 annotation cites evidence transferred from UniProtKB:Q8CG76 (ECO:0000250), not direct experimental validation for this protein.",
    "The sequence match is established for the retrieved current and historical records, but the author's exact source snapshot is unknown."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The available matched-sequence annotation supports D; no other listed option is supported as the proton donor."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "active_site_0041",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The matched UniProt record annotates residue 58 as the proton donor, supporting choice D. The annotation is transferred by similarity rather than direct experimental evidence for this sequence.",
    "evidence_ids": ["C1", "C5", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence alone does not provide a reliable way to distinguish which listed residue is the proton donor; the out-of-range position in A is readily excluded, but that does not identify the catalytic residue.",
    "missing_item_specific_fact": "The protein-specific active-site annotation identifying residue 58 as the proton donor, or equivalent experimental or homology evidence.",
    "reason": "The exact residue and catalytic role are protein-specific facts not established by the supplied sequence and choices through general biological reasoning."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The available matched-sequence annotation supports D; no other listed option is supported as the proton donor."
  },
  "important_caveats": [
    "The residue-58 annotation cites evidence transferred from UniProtKB:Q8CG76 (ECO:0000250), not direct experimental validation for this protein.",
    "The sequence match is established for the retrieved current and historical records, but the author's exact source snapshot is unknown."
  ]
}
```

</details>

## Qwen3.8-Flash-Next-NVFP4

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt entry A0A9E7S5B9 (Rhazimal reductase 2, EC 1.1.1.440, from Alstonia scholaris) annotates position 58 as 'Active site – Proton donor' (evidence ECO:0000250, inferred by similarity to Q8CG76). The residue at position 58 in the supplied 323-aa sequence is Y (Tyrosine), consistent with the canonical SDR-family catalytic Tyr. The annotation is a computational transfer rather than direct experimental proof for this specific protein, but the SDR Tyr-Lys-Ser catalytic mechanism is well established. Choice A (position 2886) is impossible since the protein is only 323 residues long and is not a β-ketoacyl synthase. Choices B (position 125, Arg) and C (position 157, Lys) do not correspond to annotated active-site residues.

Citations as saved: [C5](#evidence-c5), [H3](#evidence-h3), [C4](#evidence-c4), [C1](#evidence-c1).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The protein is a short-chain dehydrogenase/reductase (SDR) family enzyme (EC 1.1.1.440, NADP⁺-dependent). The SDR catalytic mechanism is textbook biochemistry: a catalytic Tyr acts as the proton donor, a Lys serves as a proton relay, and a Ser assists substrate positioning. Among the choices, position 58 is Y (Tyr) located in the NAD(P)-binding Rossmann-fold region (near the annotated NADP⁺ binding site at position 53), matching the canonical SDR proton-donor role. Position 125 is Arg (not a typical SDR catalytic residue), and position 157 is Lys (the SDR Lys is a proton relay, not typically labelled 'proton acceptor' in the same mechanistic sense). Position 2886 exceeds the 323-residue protein length and references an unrelated enzyme class, making it trivially eliminable.


**Missing item-specific fact**

> None strictly required; the SDR catalytic tetrad mechanism (Tyr proton donor, Lys relay, Ser substrate binding) is general enzyme biochemistry. However, pinpointing the exact residue number 58 from the raw sequence without family-specific structural knowledge is non-trivial.


**Reason**

> A model with knowledge of SDR-family enzymology can reason: (1) EC 1.1.1.x oxidoreductase with NADP⁺ binding → SDR family; (2) SDR proton donor is a catalytic Tyr; (3) locate Tyr in the NAD(P)-binding region → position 58. The distractors are eliminable by general principles (Arg is not a catalytic residue in SDR; the Lys in SDR is a relay, not 'proton acceptor'; position 2886 is out of range). This constitutes a defensible biological argument from general knowledge, though it requires SDR-family-specific mechanistic knowledge beyond generic sequence heuristics.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Choice A is eliminated by sequence length (323 aa < 2886). Choice B (Arg at 125) is not a recognized catalytic residue in SDR enzymes. Choice C (Lys at 157) mislabels the SDR Lys role as 'proton acceptor' rather than 'proton relay' and is not annotated as an active site. Only D (Tyr at 58, proton donor) matches both the SDR mechanism and the UniProt annotation.


### Important caveats

- The active-site annotation at position 58 carries evidence code ECO:0000250 (inferred by similarity to Q8CG76), meaning it is a computational transfer annotation, not direct experimental evidence for this specific Rhazimal reductase 2.
- The protein sequence alone does not explicitly state the EC number or family membership; a model must infer SDR family identity from sequence features or training knowledge.
- The NAD(P)-binding motif in this protein does not perfectly match the canonical SDR 'TGxxxGG' motif, making pure motif-based identification of the NAD-binding region somewhat less straightforward.
- The UniProt entry was first publicly released 2025-06-18; the historical snapshot (entry version 13) confirms the same annotation, but the author's construction date is unknown.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The protein is a short-chain dehydrogenase/reductase (SDR) family enzyme (EC 1.1.1.440, NADP⁺-dependent). The SDR catalytic mechanism is textbook biochemistry: a catalytic Tyr acts as the proton donor, a Lys serves as a proton relay, and a Ser assists substrate positioning. Among the choices, position 58 is Y (Tyr) located in the NAD(P)-binding Rossmann-fold region (near the annotated NADP⁺ binding site at position 53), matching the canonical SDR proton-donor role. Position 125 is Arg (not a typical SDR catalytic residue), and position 157 is Lys (the SDR Lys is a proton relay, not typically labelled 'proton acceptor' in the same mechanistic sense). Position 2886 exceeds the 323-residue protein length and references an unrelated enzyme class, making it trivially eliminable.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "None strictly required; the SDR catalytic tetrad mechanism (Tyr proton donor, Lys relay, Ser substrate binding) is general enzyme biochemistry. However, pinpointing the exact residue number 58 from the raw sequence without family-specific structural knowledge is non-trivial.",
    "reason": "A model with knowledge of SDR-family enzymology can reason: (1) EC 1.1.1.x oxidoreductase with NADP⁺ binding → SDR family; (2) SDR proton donor is a catalytic Tyr; (3) locate Tyr in the NAD(P)-binding region → position 58. The distractors are eliminable by general principles (Arg is not a catalytic residue in SDR; the Lys in SDR is a relay, not 'proton acceptor'; position 2886 is out of range). This constitutes a defensible biological argument from general knowledge, though it requires SDR-family-specific mechanistic knowledge beyond generic sequence heuristics."
  },
  "case_id": "active_site_0041",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H3",
      "C4",
      "C1"
    ],
    "judgment": "supported",
    "reason": "The UniProt entry A0A9E7S5B9 (Rhazimal reductase 2, EC 1.1.1.440, from Alstonia scholaris) annotates position 58 as 'Active site – Proton donor' (evidence ECO:0000250, inferred by similarity to Q8CG76). The residue at position 58 in the supplied 323-aa sequence is Y (Tyrosine), consistent with the canonical SDR-family catalytic Tyr. The annotation is a computational transfer rather than direct experimental proof for this specific protein, but the SDR Tyr-Lys-Ser catalytic mechanism is well established. Choice A (position 2886) is impossible since the protein is only 323 residues long and is not a β-ketoacyl synthase. Choices B (position 125, Arg) and C (position 157, Lys) do not correspond to annotated active-site residues."
  },
  "important_caveats": [
    "The active-site annotation at position 58 carries evidence code ECO:0000250 (inferred by similarity to Q8CG76), meaning it is a computational transfer annotation, not direct experimental evidence for this specific Rhazimal reductase 2.",
    "The protein sequence alone does not explicitly state the EC number or family membership; a model must infer SDR family identity from sequence features or training knowledge.",
    "The NAD(P)-binding motif in this protein does not perfectly match the canonical SDR 'TGxxxGG' motif, making pure motif-based identification of the NAD-binding region somewhat less straightforward.",
    "The UniProt entry was first publicly released 2025-06-18; the historical snapshot (entry version 13) confirms the same annotation, but the author's construction date is unknown."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Choice A is eliminated by sequence length (323 aa < 2886). Choice B (Arg at 125) is not a recognized catalytic residue in SDR enzymes. Choice C (Lys at 157) mislabels the SDR Lys role as 'proton acceptor' rather than 'proton relay' and is not annotated as an active site. Only D (Tyr at 58, proton donor) matches both the SDR mechanism and the UniProt annotation."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "active_site_0041",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The UniProt entry A0A9E7S5B9 (Rhazimal reductase 2, EC 1.1.1.440, from Alstonia scholaris) annotates position 58 as 'Active site – Proton donor' (evidence ECO:0000250, inferred by similarity to Q8CG76). The residue at position 58 in the supplied 323-aa sequence is Y (Tyrosine), consistent with the canonical SDR-family catalytic Tyr. The annotation is a computational transfer rather than direct experimental proof for this specific protein, but the SDR Tyr-Lys-Ser catalytic mechanism is well established. Choice A (position 2886) is impossible since the protein is only 323 residues long and is not a β-ketoacyl synthase. Choices B (position 125, Arg) and C (position 157, Lys) do not correspond to annotated active-site residues.",
    "evidence_ids": ["C5", "H3", "C4", "C1"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The protein is a short-chain dehydrogenase/reductase (SDR) family enzyme (EC 1.1.1.440, NADP⁺-dependent). The SDR catalytic mechanism is textbook biochemistry: a catalytic Tyr acts as the proton donor, a Lys serves as a proton relay, and a Ser assists substrate positioning. Among the choices, position 58 is Y (Tyr) located in the NAD(P)-binding Rossmann-fold region (near the annotated NADP⁺ binding site at position 53), matching the canonical SDR proton-donor role. Position 125 is Arg (not a typical SDR catalytic residue), and position 157 is Lys (the SDR Lys is a proton relay, not typically labelled 'proton acceptor' in the same mechanistic sense). Position 2886 exceeds the 323-residue protein length and references an unrelated enzyme class, making it trivially eliminable.",
    "missing_item_specific_fact": "None strictly required; the SDR catalytic tetrad mechanism (Tyr proton donor, Lys relay, Ser substrate binding) is general enzyme biochemistry. However, pinpointing the exact residue number 58 from the raw sequence without family-specific structural knowledge is non-trivial.",
    "reason": "A model with knowledge of SDR-family enzymology can reason: (1) EC 1.1.1.x oxidoreductase with NADP⁺ binding → SDR family; (2) SDR proton donor is a catalytic Tyr; (3) locate Tyr in the NAD(P)-binding region → position 58. The distractors are eliminable by general principles (Arg is not a catalytic residue in SDR; the Lys in SDR is a relay, not 'proton acceptor'; position 2886 is out of range). This constitutes a defensible biological argument from general knowledge, though it requires SDR-family-specific mechanistic knowledge beyond generic sequence heuristics."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Choice A is eliminated by sequence length (323 aa < 2886). Choice B (Arg at 125) is not a recognized catalytic residue in SDR enzymes. Choice C (Lys at 157) mislabels the SDR Lys role as 'proton acceptor' rather than 'proton relay' and is not annotated as an active site. Only D (Tyr at 58, proton donor) matches both the SDR mechanism and the UniProt annotation."
  },
  "important_caveats": [
    "The active-site annotation at position 58 carries evidence code ECO:0000250 (inferred by similarity to Q8CG76), meaning it is a computational transfer annotation, not direct experimental evidence for this specific Rhazimal reductase 2.",
    "The protein sequence alone does not explicitly state the EC number or family membership; a model must infer SDR family identity from sequence features or training knowledge.",
    "The NAD(P)-binding motif in this protein does not perfectly match the canonical SDR 'TGxxxGG' motif, making pure motif-based identification of the NAD-binding region somewhat less straightforward.",
    "The UniProt entry was first publicly released 2025-06-18; the historical snapshot (entry version 13) confirms the same annotation, but the author's construction date is unknown."
  ]
}
```

</details>

## Existing project source checks of Luna’s review

The notes below were prepared for specific claims in the Luna review. They are not independent validation of Qwen’s claims, expert adjudication, or replacement verdicts.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Reviewer-only source evidence

**Both reviewers received this source evidence separately from the original question. It was not available to the original evaluated model.** Source support and reasoning from the original sequence/choices are distinct assessments.

**Accession:** `A0A9E7S5B9` (recovered from dataset image-path metadata, not original question text).  
**Sequence applicability:** historical matched; current matched.  
**Historical cutoff:** 2026-05-07; archived entry version 13. Exact author snapshot unknown.

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A9E7S5B9.json)  
**Locator:** `/primaryAccession`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-01T06:24:54.300761+00:00.  

```json
"A0A9E7S5B9"
```

Source SHA-256: `1c08163802b289b90c328d14948f43d22b2f958ae0fc9ab7cce8f8e6c8cfdb11`.

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A9E7S5B9.json)  
**Locator:** `/proteinDescription`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-01T06:24:54.300761+00:00.  

```json
{"recommendedName":{"ecNumbers":[{"evidences":[{"evidenceCode":"ECO:0000269","id":"36349266","source":"PubMed"}],"value":"1.1.1.440"}],"fullName":{"evidences":[{"evidenceCode":"ECO:0000303","id":"36349266","source":"PubMed"}],"value":"Rhazimal reductase 2"},"shortNames":[{"evidences":[{"evidenceCode":"ECO:0000303","id":"36349266","source":"PubMed"}],"value":"AsRHR2"}]}}
```

Source SHA-256: `1c08163802b289b90c328d14948f43d22b2f958ae0fc9ab7cce8f8e6c8cfdb11`.

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A9E7S5B9.json)  
**Locator:** `/features/1`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-01T06:24:54.300761+00:00.  

```json
{"description":"Proton donor","evidences":[{"evidenceCode":"ECO:0000250","id":"Q8CG76","source":"UniProtKB"}],"location":{"end":{"modifier":"EXACT","value":58},"start":{"modifier":"EXACT","value":58}},"type":"Active site"}
```

Source SHA-256: `1c08163802b289b90c328d14948f43d22b2f958ae0fc9ab7cce8f8e6c8cfdb11`.

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A9E7S5B9?format=txt&versions=13)  
**Locator:** `lines 72-74`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 13 / 1.  
**Retrieved:** 2026-11-01T06:27:37.410633+00:00.  

```text
FT   ACT_SITE        58
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000250|UniProtKB:Q8CG76"
```

Source SHA-256: `e4dda31c04daf5f332a19bce2a18fad48f65a392722189ae93f6d3e440e89922`.

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/active_site.json), zero-based source row 41. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). UniProt and Gene Ontology credits are retained in [source notices](../THIRD_PARTY_NOTICES.md).
